Jeannine Gingras, MD
Sleep Medicine · Charlotte, NCNPI 1861455651
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by ZOLL Respicardia, Inc. at 45.5% of the total. Reporting peaked in 2022 at $1,367 and has fallen 60.3% since, to $542 in 2023.
Across 59 payments — averaging $42.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Respicardia, Inc.$1K
- Jazz Pharmaceuticals Inc.$503
- Arbor Pharmaceuticals, Inc.$210
- Harmony Biosciences LLC$173
- Axsome Therapeutics, Inc.$162
- UCB, Inc.$148
- plus $171 from 5 others
What the payments were for
- Travel & lodging$1,14045%
- Food & beverage$1,21749%
- Education$1516%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Respicardia, Inc. | 1 | $1,140 |
| Jazz Pharmaceuticals Inc. | 16 | $503 |
| Arbor Pharmaceuticals, Inc. | 12 | $210 |
| Harmony Biosciences LLC | 6 | $173 |
| Axsome Therapeutics, Inc. | 7 | $162 |
| UCB, Inc. | 7 | $148 |
| Eisai Inc. | 4 | $67 |
| Idorsia Pharmaceuticals US Inc | 3 | $60 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- remede System$1,140
- XYWAV$125
How this compares
$2,508 in reported general payments places this provider in the 80th percentile of 52 sleep medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ropinirole Hcl | 12 | $130 |
| Gabapentin | 14 | $105 |
| Zolpidem Tartrate | 16 | $86 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Charlotte
- Douglas KirschCharlotte$26K
- Meredith SnappCharlotte$2K
- Bianca StewartCharlotte$2K
- Kimberly MimsCharlotte$1K
- Steve ChungCharlotte$1K
- Jacob ColemanCharlotte$1K
- Ehrlich TanCharlotte$801
- William ClemonsCharlotte$385
- Adedayo OgunleyeCharlotte$219
- Dharmeshkumar SuratwalaCharlotte$157
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.